Its important to note that discontinuing GLP-1 injections may lead to weight regain, so long-term commitment and partnership with your healthcare provider are key to maintaining your results
NHS Route Cost: 9.90 per prescription (England) or free (Scotland/Wales) Eligibility: BMI 40+ with 4+ comorbidities (Cohort 1 only) Wait: 118 months depending on region Includes: Behavioural support, dietetic advice, clinical monitoring Private Route Cost: 120340/month depending on dose and pharmacy Eligibility: BMI 30+ (or 27+ with weight-related condition) Wait: Typically 2448 hours Includes: Varies some include full support, others medication only NHS eligibility in detail (March 2026) NICE published its finalised guidance on tirzepatide for managing overweight and obesity (TA1026) in December 2024
Who Is at Higher Risk Certain individuals may be at higher risk of hair loss, including those with a history of thinning hair, nutritional deficiencies, or hormonal changes, particularly when poor nutrition and dietary imbalances are present
IGF-1 axis changes with ADT and docetaxel in metastatic prostate oncology research models [PMID: 37671811] Laboratory literature summary: IGF-1 axis changes with ADT and docetaxel in metastatic prostate oncology research models
At 12mg weekly, 4mg per injection
